TRANSPLANTATION OF SUBRETINAL STEM CELL-DERIVED RETINAL PIGMENT EPITHELIUM FOR STARGARDT DISEASE: A Phase I Clinical Trial

Summary

This surgical procedure was feasible and safe without cellular migration, rejection, inflammation, or development of ocular or systemic tumors during follow-up.

Authors	Brant Fernandes RA, Lojudice FH, Zago Ribeiro L, Santos da Cruz NF, Polizelli MU, Cristovam PC, Innocenti F, Morimoto L, Magalhães O Jr, Ferraz Sallum JM, Penha FM, Sogayar MC, Belfort R Jr, Maia M
Journal	Retina (Philadelphia, Pa.)
Publication Date	2023 Feb 1;43(2):263-274
PubMed	36223778
DOI	10.1097/iae.0000000000003655

Research Projects

Cell Lines

• (none)